Abstract:Objective: Cancer is a complex genetic disease characterized by the accumulation of various mutations, with driver genes playing a crucial role in cancer initiation and progression. Distinguishing driver genes from passenger mutations is essential for understanding cancer biology and discovering therapeutic targets. However, the majority of existing methods ignore the mutational heterogeneity and commonalities among patients, which hinders the identification of driver genes more effectively. Methods: This study introduces MCSdriver, a novel computational model that integrates network and pathway information to prioritize the identification of cancer driver genes. MCSdriver employs a bidirectional random walk algorithm to quantify the mutual exclusivity and functional relationships between mutated genes within patient cohorts. It calculates similarity scores based on a mutual exclusivity-weighted network and pathway coverage patterns, accounting for patient-specific heterogeneity and molecular profile similarity. Results: This approach enhances the accuracy and quality of driver gene identification. MCSdriver demonstrates superior performance in identifying cancer driver genes across four cancer types from The Cancer Genome Atlas, showing a higher F-score, Recall and Precision compared to existing ranking list-based and module-based models. Conclusion: The MCSdriver model not only outperforms other models in identifying known cancer driver genes but also effectively identifies novel driver genes involved in cancer-related biological processes. The model's consideration of patient-specific heterogeneity and similarity in molecular profiles significantly enhances the accuracy and quality of driver gene identification. Validation through Gene Ontology enrichment analysis and literature mining further underscores its potential application value in personalized cancer therapy, offering a promising tool for advancing our understanding and treatment of cancer.

Cancer Core Modules Identification Through Genomic and Transcriptomic Changes Correlation Detection at Network Level.

Identification of Cancer Driver Modules by Combining Network Functional and Topology Information.

Identifying Cancer Specific Driver Modules Using A Network-Based Method

Integrative analysis of dysfunctional modules driven by genomic alterations at system level across 11 cancer types.

Identification of Driver Genes Based on Gene Mutational Effects and Network Centrality

Enhancing Cancer Driver Gene Prediction by Protein-Protein Interaction Network

Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.

Advancing cancer driver gene identification through an integrative network and pathway approach

Identification of Driver Network Modules in Protein-Protein Interaction Network Using Patient Mutation Profiles

Cooperative Driver Module Identification Based on Single Cell Data

Identification of Common Driver Gene Modules and Associations between Cancers through Integrated Network Analysis

Identifying driver modules based on multi‐omics biological networks in prostate cancer

PathDriver: Cancer Driver Genes Identification Based on the Metabolic Pathway

Identification of driver modules in pan-cancer via coordinating coverage and exclusivity

The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.

Integrating Protein-Protein Interaction Networks and Somatic Mutation Data to Detect Driver Modules in Pan-Cancer

Identification of Cancer Driver Modules Based on Graph Clustering from Multiomics Data

Identifying Driver Genes Involving Gene Dysregulated Expression, Tissue-Specific Expression and Gene-Gene Network

Detection of Driver Modules with Rarely Mutated Genes in Cancers

Identifying Hepatocellular Carcinoma Driver Genes by Integrative Pathway Crosstalk and Protein Interaction Network

Detection Of Driver Pathways Using Mutated Gene Network In Cancer